Panel Member	Clinical Research Support	Advisory Boards, Speakers Bureau, Expert Witness, or Consultant	Patent, Equity, or Royalty	Other	Date Completed
Jeremy S. Abramson, MD	None	Genzyme Corporation; Novartis Pharmaceuticals Corporation	None	None	6/16/2010
Ranjana H. Advani, MD	Allos	Allos	None	None	11/30/2009
C. Babis Andreadis, MD, MSCE	None	Allos	None	Roche Laboratories, Inc.	4/8/2010
Nancy Bartlett, MD	None	None	None	None	6/8/2010
John C. Byrd, MD	None	None	None	None	1/7/2010
Myron S. Czuczman, MD	Biogen Idec; Celgene Corporation; Centocor, Inc.; Cephalon, Inc.; GlaxoSmithKline; Novartis Pharmaceuticals Corporation	Abbott Laboratories; Amgen Inc.; Biogen Idec; Celgene Corporation; Cephalon, Inc.; Genentech, Inc.; GlaxoSmithKline; Millennium Pharmaceuticals, Inc.; Novartis Pharmaceuticals Corporation	None	None	9/28/2009
Mary Dwyer, MS	None	None	None	None	7/15/2010
Luis E Fayad, MD	Eli Lilly and Company; Genentech, Inc.; GlaxoSmithKline; Wyeth Pharmaceuticals	Cell Therapeutics, Inc.; Cephalon, Inc.; Eli Lilly and Company; Genentech, Inc.; Wyeth Pharmaceuticals	None	None	12/17/2009
Andres Forero, MD	Biogen Idec; Daiichi- Sankyo Co.; Eli Lilly and Company; Genentech, Inc.; BioCryst; Immunomedics; Seattle Genetics	None	None	None	9/28/2009
Lauren Gallagher, RPh, PhD	None	None	None	None	8/23/2010
Martha J. Glenn, MD	; Piramal Life Sciences; sanofi-aventis U.S.	None	None	None	12/16/2009
Jon P. Gockerman, MD	None	None	None	None	12/4/2009
Leo I. Gordon, MD	CureTech Ltd.; Genentech, Inc.; Millennium Pharmaceuticals, Inc.; Pharmacyclics	CureTech Ltd.	None	CureTech Ltd.	7/21/2009
Kristina M. Gregory, RN, MSN, OCN	None	None	None	None	8/30/2010
Nancy Lee Harris, MD	None	None	None	None	7/10/2009
Richard T. Hoppe, MD	None	None	None	None	7/22/2009
Steven M. Horwitz, MD	Genzyme Corporation; ; Allos; Gloucester	Celgene Corporation; Merck & Co., Inc.; Millennium Pharmaceuticals, Inc.; allos; gloucester; Seattle Genetics	None	None	4/16/2010
Christopher R. Kelsey, MD	None	None	None	None	7/12/2010
Youn H. Kim, MD	Merck & Co., Inc.; Allos; Gloucester; Kyowa Hakko Kirin Co.; TenX BioPharma; Yaupon	Celgene Corporation; Eisai Inc.; Merck & Co., Inc.; Gloucester; Seattle Genetics; Therakos, Inc.	None	None	6/16/2010
Ann S. LaCasce, MD	None	None	None	None	7/6/2009
Joan S. McClure, MS	None	None	None	None	7/18/2010
Auayporn Nademanee, MD	Genzyme Corporation; Seattle Genetics Co.	Allos Company; Spectrum Therapeutic	None	None	6/16/2010
Pierluigi Porcu, MD	None	Therakos, Inc.	None	None	7/13/2009
Oliver Press, MD, PhD	Genentech, Inc.; Roche Laboratories, Inc.	Genentech, Inc.; Roche Laboratories, Inc.	None	None	4/12/2010
Barbara Pro, MD	None	None	None	None	8/20/2010
Nishitha Reddy, MD	None	None	None	None	1/11/2010
Lubomir Sokol, MD, PhD	None	Eisai Inc.; Allos; Gloucester	None	None	4/12/2010
Hema Sundar, PhD	None	None	None	Cephalon, Inc.	7/19/2010
Lode J. Swinnen, MB, ChB	None	Abbott Laboratories; Genentech, Inc.	None	None	12/18/2009
Christina Tsien, MD					Pending
Julie M. Vose, MD	Applied Medical Resources Corporation; Bristol-Myers Squibb Company; Celgene Corporation; Genentech, Inc.; Genzyme Corporation; GlaxoSmithKline; Millennium Pharmaceuticals, Inc.; Novartis Pharmaceuticals Corporation; Allos Therapeutics; AnorMed, Inc.; Astellas; Rigel; Pharmacyclics	None	None	None	12/18/2009
William G Wierda, MD, PhD	Abbott Laboratories; Bayer HealthCare; Genitope; Genmab; Memgen; sanofi-aventis U.S.; Sunesis Pharmaceuticals, Inc.	Celgene Corporation; Cephalon, Inc.; Genentech, Inc.; Genzyme Corporation; Micromet; sanofi-aventis U.S.; Schering-Plough Corporation	None	None	2/22/2010
Joachim Yahalom, MD	None	None	None	None	11/20/2009
Nadeem Zafar, MD					Pending
Andrew D. Zelenetz, MD, PhD	Abbott Laboratories; Cephalon, Inc.; GlaxoSmithKline; Allos Pharm; Glouster Pharm; Roche; Seattle Genetics	Bristol-Myers Squibb Company; Cephalon, Inc.; Eli Lilly and Company; Genentech, Inc.; GlaxoSmithKline; Allos; Cancer Genetics; sanofi-aventis U.S.	None	None	12/21/2009

NCCN Website Supporters